Javascript must be enabled to continue!
Data from Stromal LRP1 in Lung Adenocarcinoma Predicts Clinical Outcome
View through CrossRef
<div>Abstract<p><b>Purpose:</b> LRP1 (low-density lipoprotein receptor–related protein 1) is a broadly expressed receptor that binds multiple extracellular ligands and participates in protein clearance. It is expressed in numerous cancers, but its role in lung cancer has not been characterized. Here, we investigate the relationship between LRP1 and lung cancer.</p><p><b>Experimental Design:</b><i>LRP1</i> mRNA levels were determined in lung tumors from several large, multicenter studies. LRP1 protein localization was determined by immunohistochemical analysis of lung tumor microarrays. Normal fibroblasts, fibroblasts treated with the LRP1 inhibitor RAP (receptor-associated protein), and <i>Lrp1</i> null fibroblasts were cocultured with 3 independent lung cancer cell lines to investigate the role of LRP1 on tumor cell proliferation.</p><p><b>Results:</b><i>LRP1</i> mRNA levels are significantly decreased in lung tumors relative to nontumorous lung tissue. Lower expression of <i>LRP1</i> in lung adenocarcinomas correlates with less favorable clinical outcome in a cohort of 439 patients. Immunohistochemical analysis shows that LRP1 is primarily expressed in stromal cells in 94/111 lung cancers, with very little protein found in cancer cells. A growth-suppressive function of mouse embryonic fibroblast (MEF) cells was observed in 3 lung cancer cell lines tested (H460, H2347, and HCC4006 cells); growth suppression was blocked by the LRP1 inhibitor RAP. <i>Lrp1</i> deletion in fibroblasts reduced the ability of MEF cells to suppress tumor cell mitosis. In a validation set of adenocarcinomas, we confirmed a significant, positive correlation between both <i>LRP1</i> mRNA and protein levels and favorable clinical outcomes.</p><p><b>Conclusions:</b><i>LRP1</i> expression is associated with improved lung cancer outcomes. Mechanistically, stromal LRP1 may non–cell autonomously suppress lung tumor cell proliferation. <i>Clin Cancer Res; 17(8); 2426–33. ©2011 AACR</i>.</p></div>
American Association for Cancer Research (AACR)
Title: Data from Stromal LRP1 in Lung Adenocarcinoma Predicts Clinical Outcome
Description:
<div>Abstract<p><b>Purpose:</b> LRP1 (low-density lipoprotein receptor–related protein 1) is a broadly expressed receptor that binds multiple extracellular ligands and participates in protein clearance.
It is expressed in numerous cancers, but its role in lung cancer has not been characterized.
Here, we investigate the relationship between LRP1 and lung cancer.
</p><p><b>Experimental Design:</b><i>LRP1</i> mRNA levels were determined in lung tumors from several large, multicenter studies.
LRP1 protein localization was determined by immunohistochemical analysis of lung tumor microarrays.
Normal fibroblasts, fibroblasts treated with the LRP1 inhibitor RAP (receptor-associated protein), and <i>Lrp1</i> null fibroblasts were cocultured with 3 independent lung cancer cell lines to investigate the role of LRP1 on tumor cell proliferation.
</p><p><b>Results:</b><i>LRP1</i> mRNA levels are significantly decreased in lung tumors relative to nontumorous lung tissue.
Lower expression of <i>LRP1</i> in lung adenocarcinomas correlates with less favorable clinical outcome in a cohort of 439 patients.
Immunohistochemical analysis shows that LRP1 is primarily expressed in stromal cells in 94/111 lung cancers, with very little protein found in cancer cells.
A growth-suppressive function of mouse embryonic fibroblast (MEF) cells was observed in 3 lung cancer cell lines tested (H460, H2347, and HCC4006 cells); growth suppression was blocked by the LRP1 inhibitor RAP.
<i>Lrp1</i> deletion in fibroblasts reduced the ability of MEF cells to suppress tumor cell mitosis.
In a validation set of adenocarcinomas, we confirmed a significant, positive correlation between both <i>LRP1</i> mRNA and protein levels and favorable clinical outcomes.
</p><p><b>Conclusions:</b><i>LRP1</i> expression is associated with improved lung cancer outcomes.
Mechanistically, stromal LRP1 may non–cell autonomously suppress lung tumor cell proliferation.
<i>Clin Cancer Res; 17(8); 2426–33.
©2011 AACR</i>.
</p></div>.
Related Results
Data from Stromal LRP1 in Lung Adenocarcinoma Predicts Clinical Outcome
Data from Stromal LRP1 in Lung Adenocarcinoma Predicts Clinical Outcome
<div>Abstract<p><b>Purpose:</b> LRP1 (low-density lipoprotein receptor–related protein 1) is a broadly expressed receptor that binds multiple extracellular ...
Complex Collision Tumors: A Systematic Review
Complex Collision Tumors: A Systematic Review
Abstract
Introduction: A collision tumor consists of two distinct neoplastic components located within the same organ, separated by stromal tissue, without histological intermixing...
Regulatory mechanisms in multiple vascular diseases locus
LRP1
involve repression by SNAIL and extracellular matrix remodeling
Regulatory mechanisms in multiple vascular diseases locus
LRP1
involve repression by SNAIL and extracellular matrix remodeling
Abstract
Background
Genome-wide association studies (GWAS) implicate common genetic variations in the low-...
Etude du récepteur d’endocytose LRP1 dans les adénocarcinomes coliques : caractéristiques cliniques, pathologiques et moléculaires associées et valeur pronostique
Etude du récepteur d’endocytose LRP1 dans les adénocarcinomes coliques : caractéristiques cliniques, pathologiques et moléculaires associées et valeur pronostique
LRP1 (low-density lipoprotein receptor–related protein 1), un récepteur endocytaire multifonctionnel, a récemment été identifié comme pivot d’un réseau de biomarqueurs pour la préd...
Minimally Invasive Thoracoscopic Surgery of Lung Adenocarcinoma in Old Age People
Minimally Invasive Thoracoscopic Surgery of Lung Adenocarcinoma in Old Age People
Background: Lung cancer is the most frequent human malignancy and the principal cause of cancer-related death worldwide. Adenocarcinoma is now the main histologic type, accounting ...
USP4 promotes proliferation and metastasis in human lung adenocarcinoma
USP4 promotes proliferation and metastasis in human lung adenocarcinoma
Abstract
Objective
Research the expression of USP4 in lung adenocarcinoma and its correlation with clinicopathological features and prognosis analysis, to explore the inva...
Microwave Ablation with or Without Chemotherapy in Management of Non-Small Cell Lung Cancer: A Systematic Review
Microwave Ablation with or Without Chemotherapy in Management of Non-Small Cell Lung Cancer: A Systematic Review
Abstract
Introduction
Microwave ablation (MWA) has emerged as a minimally invasive treatment for patients with inoperable non-small cell lung cancer (NSCLC). However, whether it i...
Multi-omics Research on the Heterogeneity and Immune Landscape of Lung Adenocarcinoma with Ground-glass opacity
Multi-omics Research on the Heterogeneity and Immune Landscape of Lung Adenocarcinoma with Ground-glass opacity
Abstract
Background:
Lung adenocarcinoma with ground-glass opacity (GGO) has been detected increasingly and now accounts for most lung cancer patients. Lung adenocarcinoma...

